HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drugstore.com

This article was originally published in The Rose Sheet

Executive Summary

Online retailer files for public offering of up to 6 mil. shares of common stock with the Securities & Exchange Commission Feb. 9. Drugstore.com is offering 4.5 mil. shares of common stock with selling stockholders offering 1.5 mil. shares. Underwriters Morgan Stanley Dean Witter, Donaldson, Lufkin & Jenrette Securities Corp., Salomon Smith Barney and Thomas Weisel Partners, may be granted an option to purchase up to an aggregate of 903,000 additional shares. The e-tailer opened its first day of trading July 28 (1"The Rose Sheet" Aug. 2, 1999, In Brief)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007646

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel